-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TILT-123 in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TILT-123 in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TILT-123 in Melanoma Drug Details: TILT-123 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TILT-123 in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TILT-123 in Sarcomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TILT-123 in Sarcomas Drug Details: TILT-123 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Iptacopan Hydrochloride in Lupus Nephritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Iptacopan Hydrochloride in Lupus Nephritis Drug Details: Iptacopan hydrochloride (Fabhalta) is a factor B inhibitor of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Erdafitinib in Thyroid Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Erdafitinib in Thyroid Cancer Drug Details: Erdafitinib (Balversa, Erfandel) is an alkyldiarylamine compound acts as...
-
Product Insights
Snowtown North Solar Farm
Snowtown North Solar Farm is a solar PV project located in South Australia, Australia. The project is owned and being developed by Tilt Renewables Ltd. The project is at the permitting stage. Empower your strategies with our Snowtown North Solar Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
Waddi Solar PV Park
Waddi Solar PV Park is a solar PV project located in Western Australia, Australia. The project is owned and being developed by Tilt Renewables Ltd. The project is at the permitting stage. Empower your strategies with our Waddi Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
Waddi Wind Farm
Waddi Wind Farm is an Onshore Wind project located in Western Australia, Australia. The project is owned by Tilt Renewables Ltd and is developed by Continental Wind Partners LLC; Tilt Renewables Ltd; Wind Prospect Pty Ltd. The project is at the permitting stage. Empower your strategies with our Waddi Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...